Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

NCT02095353 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2023-08-23

No results posted yet for this study

Summary

This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.

Conditions

  • Central Nervous System Neoplasms

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Matthew White, MD · University of Nebraska

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2017-03-07
Completion
2017-03-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02095353 on ClinicalTrials.gov